02.20.25 Large analysis of diabetic patients found increase in NAION An analysis of 37.1 million adults with type 2 diabetes across 14 databases found further evidence of an association between semaglutide and NAION. 02.04.25 MDL continued to grow leading into February The total number of cases in the GLP-1 MDL grew to 1,443
Food and Drug Administration (FDA) has mandated that compounding pharmacies cease the production of compounded versions of tirzepatide, the active ingredient in Eli Lillys Mounjaro and Zepbound
If you are in Hawaii, Alaska or a non-contiguous State, shipments will take up to 14 business days for delivery
Frequently Asked Questions Is it safe to combine retatrutide and tesamorelin for weight loss
Meanwhile, for weekly formulations, clinicians may advise skipping a dose one week prior
The degradation processes, while slowed by refrigeration, continue regardless